Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/2257960
Conclusion of this study
It is concluded that Serratia peptidase has anti-inflammatory, anti-oedemic and fibrinolytic activity and acts rapidly on localized inflammation.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
